Sarah A. Morrow

TL;DR: Despite the breadth of the literature on the epidemiology of MS in Europe, inter-study comparisons are hampered by the lack of standardization and further research should focus on regions not yet studied and the evaluation of ethnic differences in MS prevalence and incidence.

TL;DR: There is a need for future studies of MS prevalence and incidence to include uniform case definitions, employ comparable methods of ascertainment, report standardized results, and be performed on a national level, as well as the inconsistencies in methodologies and quality among the published studies.

TL;DR: The relative contributions of gray and white matter to MS‐related cognitive impairment will be discussed and the importance of interconnectivity between structures highlighted and the pressing need for longitudinal studies combining standardized neuropsychometric, paraclinical and radiographic outcomes obtained during life with post‐mortem tissue analysis after death is presented.

TL;DR: The amount of absorbed corticosteroid is similar after either steroid at these doses, suggesting that oral prednisone 1 might be a convenient, inexpensive alternative to IV methylprednisolone (IVMP) if the bioequivalent dose was known.

TL;DR: Actively bridging these gaps in a joint approach enables PwMS to take part in shared decision-making; with improved communication and reliable information, patients can make informed decisions with their HCPs, as part of their own personalised disease management.